BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38402843)

  • 1. The effect of N-methyl-D-aspartate receptor antagonists on the mismatch negativity of event-related potentials and its regulatory factors: A systematic review and meta-analysis.
    Guo X; Yu J; Quan C; Xiao J; Wang J; Zhang B; Hao X; Wu X; Liang J
    J Psychiatr Res; 2024 Apr; 172():210-220. PubMed ID: 38402843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
    Umbricht D; Koller R; Vollenweider FX; Schmid L
    Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
    Rosburg T; Kreitschmann-Andermahr I
    Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late deviance detection in rats is reduced, while early deviance detection is augmented by the NMDA receptor antagonist MK-801.
    Harms L; Fulham WR; Todd J; Meehan C; Schall U; Hodgson DM; Michie PT
    Schizophr Res; 2018 Jan; 191():43-50. PubMed ID: 28385587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the duration and frequency of deviant stimuli engender different mismatch negativity patterns in temporal lobe epilepsy.
    Hirose Y; Hara K; Miyajima M; Matsuda A; Maehara T; Hara M; Matsushima E; Ohta K; Matsuura M
    Epilepsy Behav; 2014 Feb; 31():136-42. PubMed ID: 24412859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory pre-attentive processing of Chinese tones.
    Yang LJ; Cao KL; Wei CG; Liu YZ
    Chin Med J (Engl); 2008 Dec; 121(23):2429-33. PubMed ID: 19102963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity to different deviant changes in autism spectrum disorders: A meta-analysis.
    Chen TC; Hsieh MH; Lin YT; Chan PS; Cheng CH
    Clin Neurophysiol; 2020 Mar; 131(3):766-777. PubMed ID: 31952914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic modulation of auditory information processing in the human brain.
    Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
    Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
    Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
    Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and Spectral Properties of the Auditory Mismatch Negativity and P3a Responses in Schizophrenia.
    Lundin NB; Burroughs LP; Kieffaber PD; Morales JJ; O'Donnell BF; Hetrick WP
    Clin EEG Neurosci; 2023 Jul; 54(4):409-419. PubMed ID: 35341344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects.
    Leung S; Croft RJ; Baldeweg T; Nathan PJ
    Psychopharmacology (Berl); 2007 Nov; 194(4):443-51. PubMed ID: 17611739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval.
    Javitt DC; Grochowski S; Shelley AM; Ritter W
    Electroencephalogr Clin Neurophysiol; 1998 Mar; 108(2):143-53. PubMed ID: 9566627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mismatch negativity and the P3a components of the auditory event-related potentials in autistic low-functioning subjects.
    Ferri R; Elia M; Agarwal N; Lanuzza B; Musumeci SA; Pennisi G
    Clin Neurophysiol; 2003 Sep; 114(9):1671-80. PubMed ID: 12948796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive analysis of auditory event-related potentials and network oscillations in an NMDA receptor antagonist mouse model using a novel wireless recording technology.
    Schuelert N; Dorner-Ciossek C; Brendel M; Rosenbrock H
    Physiol Rep; 2018 Aug; 6(16):e13782. PubMed ID: 30155997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch negativity in patients with major depressive disorder: A meta-analysis.
    Tseng YJ; Nouchi R; Cheng CH
    Clin Neurophysiol; 2021 Oct; 132(10):2654-2665. PubMed ID: 34456164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental trajectory of mismatch negativity and visual event-related potentials in healthy controls: Implications for neurodevelopmental vs. neurodegenerative models of schizophrenia.
    Corcoran CM; Stoops A; Lee M; Martinez A; Sehatpour P; Dias EC; Javitt DC
    Schizophr Res; 2018 Jan; 191():101-108. PubMed ID: 29033283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMN-Indexed Auditory Change Detection in Major Depressive Disorder.
    Bissonnette JN; Francis AM; Hull KM; Leckey J; Pimer L; Berrigan LI; Fisher DJ
    Clin EEG Neurosci; 2020 Nov; 51(6):365-372. PubMed ID: 32345046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Javitt DC; Lee M; Kantrowitz JT; Martinez A
    Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.